檢索結果 - Razak, Albiruni

The Utility of Hedgehog Signaling Pathway Inhibition for Cancer 由 Sahebjam, Solmaz, Siu, Lillian L., Razak, Albiruni A.

獲取全文 獲取全文 獲取全文

Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease 由 Abdul Razak, Albiruni Ryan, Li, Louise, Bryant, Andrew, Diaz-Padilla, Ivan

獲取全文 獲取全文 獲取全文

Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents 由 Le Tourneau, Christophe, Gan, Hui K., Razak, Albiruni R. A., Paoletti, Xavier

獲取全文 獲取全文 獲取全文

Early phase clinical trials to identify optimal dosing and safety 由 Cook, Natalie, Hansen, Aaron R., Siu, Lillian L., Abdul Razak, Albiruni R.

獲取全文 獲取全文 獲取全文

Tracheobronchial Amyloidosis: Utilization of Radiotherapy As a Treatment Modality 由 Poovaneswaran, Sangeetha, Abdul Razak, Albiruni Ryan, Lockman, Hilmi, Bone, Michael, Pollard, Kenneth, Mazdai, Goudarz

獲取全文 獲取全文

Muscular Metastasis, A Rare Presentation of Non-Small-Cell Lung Cancer 由 Razak, Albiruni Ryan Abdul, Chhabra, Rajiv, Hughes, Andrew, England, Simon, Dildey, Petra, McMenemin, Rhona

獲取全文 獲取全文

The Future of Clinical Trials Design in Oncology 由 Spreafico, Anna, Hansen, Aaron R., Abdul Razak, Albiruni R., Bedard, Philippe L., Siu, Lillian L.

獲取全文 獲取全文 獲取全文

Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial 由 Van Tine, Brian A, Krarup-Hansen, Anders, Hess, Lisa M, Abdul Razak, Albiruni R, Soldatenkova, Victoria, Wright, Jennifer, Park, Se Hoon

獲取全文 獲取全文 獲取全文

Use of expansion cohorts in phase 1 trials and probability of success in phase 2 for 381 anticancer drugs 由 Bugano, Diogo D. G., Hess, Kenneth, Jardim, Denis L. F., Zer, Alona, Meric-Bernstam, Funda, Siu, Lillian L., Razak, Albiruni, Hong, David S.

獲取全文 獲取全文 獲取全文

Feasibility Assessment of Using the Complete Patient‐Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO‐CTCAE) Item Library 由 Shepshelovich, Daniel, McDonald, Kate, Spreafico, Anna, Razak, Albiruni R.A., Bedard, Philippe L., Siu, Lillian L., Minasian, Lori, Hansen, Aaron R.

獲取全文 獲取全文 獲取全文

Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor 由 Al‐Ezzi, Esmail, Gounder, Mrinal, Watson, Geoffrey, Mazzocca, Alessandro, D'Angelo, Sandra P., Bravetti, Julie, Wang, Hongwei, Abdul Razak, Albiruni, Vincenzi, Bruno

獲取全文 獲取全文 獲取全文

Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era 由 Tan, Tira, Rheaume, Michael, Wang, Lisa, Chow, Helen, Spreafico, Anna, Hansen, Aaron R., Razak, Albiruni R.A., Siu, Lillian L., Bedard, Philippe L.

獲取全文 獲取全文 獲取全文

Clinical outcomes of non‐osteogenic, non‐Ewing soft‐tissue sarcoma of bone––experience of the Toronto Sarcoma Program 由 Veitch, Zachary W., Fasih, Samir, Griffin, Anthony M., Al‐Ezzi, Esmail M., Gupta, Abha A., Ferguson, Peter C., Wunder, Jay S., Abdul Razak, Albiruni R.

獲取全文 獲取全文 獲取全文

Ending 40 years of silence: Rationale for a new staging system for soft tissue sarcoma of the head and neck 由 Hahn, Ezra, Huang, Shao Hui, Hosni, Ali, Razak, Albiruni Abdul, Jones, Robin L., Dickson, Brendan C., Sturgis, Erich M., Patel, Snehal G., O'Sullivan, Brian

獲取全文 獲取全文 獲取全文

Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials 由 Hansen, Aaron R., Cook, Natalie, Ricci, M. Stacey, Razak, Albiruni, Le Tourneau, Christophe, McKeever, Kathleen, Roskos, Lorin, Dixit, Rakesh, Siu, Lillian L., Hinrichs, Mary Jane

獲取全文 獲取全文 獲取全文

Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials 由 Veitch, Zachary W, Shepshelovich, Daniel, Gallagher, Christina, Wang, Lisa, Abdul Razak, Albiruni R, Spreafico, Anna, Bedard, Philippe L, Siu, Lillian L, Minasian, Lori, Hansen, Aaron R

獲取全文 獲取全文 獲取全文

A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS) 由 Veitch, Zachary, Zer, Alona, Loong, Herbert, Salah, Samer, Masood, Maryam, Gupta, Abha, Bradbury, Penelope A., Hogg, David, Wong, Andrew, Kandel, Rita, Charames, George S., Abdul Razak, Albiruni R.

獲取全文 獲取全文 獲取全文

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care 由 Miller, Fiona A, Hayeems, Robin Z, Bytautas, Jessica P, Bedard, Philippe L, Ernst, Scott, Hirte, Hal, Hotte, Sebastien, Oza, Amit, Razak, Albiruni, Welch, Stephen, Winquist, Eric, Dancey, Janet, Siu, Lillian L

獲取全文 獲取全文 獲取全文

Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry 由 Music, Milena, Iafolla, Marco, Soosaipillai, Antoninus, Batruch, Ihor, Prassas, Ioannis, Pintilie, Melania, Hansen, Aaron R., Bedard, Philippe L., Lheureux, Stephanie, Spreafico, Anna, Razak, Albiruni Abdul, Siu, Lillian L., Diamandis, Eleftherios P.

獲取全文 獲取全文 獲取全文

Primary cardiac sarcomas: A multi‐national retrospective review 由 Chen, Tom Wei‐Wu, Loong, Herbert H., Srikanthan, Amirrtha, Zer, Alona, Barua, Reeta, Butany, Jagdish, Cusimano, Robert J., Liang, Yun‐Chieh, Chang, Chin‐Hao, Iakobishvili, Zaza, Razak, Albiruni R. Abdul, Lewin, Jeremy

獲取全文 獲取全文 獲取全文